LONDON–(BUSINESS WIRE)–Jul 28, 2022–
ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer and Shionogi as shareholders, today announced new efficacy and safety findings from the unblinded period of the HIV Prevention Trials…
Discussion about this post